Posted January 13, 2019 09:18:49The pharmacy chain Sam’s Clubs is in trouble with the Food and Drug Administration over its pricing of certain products, including a generic version of a drug.
Sam’s is one of many chains to face the consequences of the drug shortages plaguing the U.S. as the opioid epidemic sweeps through the country.
In addition to its generic drug Samodie, Sam’s also sells Samet, a prescription painkiller, and the other generic versions of Vicodin, OxyContin, and codeine.
The pharmacy chains’ pricing, however, is far more egregious than other chains.
Sam’s said it sells Vicodine for less than half the price of the generic version and that its generic version has the same potency as its generic counterpart.
It also charges Samet about twice as much as its equivalent version in the same class of pills, according to the pharmacy chain’s chief executive.
Samet costs $100 more than its generic price, according the chain’s website.
The FDA has opened an investigation into Sam’s for its alleged price-gouging, but has not levied a fine against the chain, which is subject to the rules of the agency.
Samets chief executive said the company will fight the FDA’s actions, which have caused its business to take a hit.
“I think it’s ridiculous that it would do this to a company that is a trusted name and is a leader in the industry,” he said.
The chain said it will not stop selling the generic versions.